Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-010391
Filing Date
2005-03-10
Accepted
2005-03-10 15:42:47
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-4774_110k.htm 10-K 1510289
2 EX-10.8 a05-4774_1ex10d8.htm EX-10.8 10202
3 EX-10.9 a05-4774_1ex10d9.htm EX-10.9 349182
4 EX-10.10 a05-4774_1ex10d10.htm EX-10.10 116521
5 EX-10.24 a05-4774_1ex10d24.htm EX-10.24 195741
6 EX-10.25 a05-4774_1ex10d25.htm EX-10.25 1085853
7 EX-21.1 a05-4774_1ex21d1.htm EX-21.1 1294
8 EX-23.1 a05-4774_1ex23d1.htm EX-23.1 3249
9 EX-31.1 a05-4774_1ex31d1.htm EX-31.1 11405
10 EX-31.2 a05-4774_1ex31d2.htm EX-31.2 11455
11 EX-32 a05-4774_1ex32.htm EX-32 10807
  Complete submission text file 0001104659-05-010391.txt   3308538
Mailing Address
Business Address 10301 STELLA LINK HOUSTON TX 77025 7136642288
TANOX INC (Filer) CIK: 0001099414 (see all company filings)

EIN.: 760196733 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30231 | Film No.: 05672400
SIC: 2834 Pharmaceutical Preparations